Investigational Drug Information for SB-705498
✉ Email this page to a colleague
What is the drug development status for SB-705498?
SB-705498 is an investigational drug.
There have been 9 clinical trials for SB-705498.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 26th 2007.
The most common disease conditions in clinical trials are Rhinitis, Toothache, and Cough. The leading clinical trial sponsors are GlaxoSmithKline and [disabled in preview].
Summary for SB-705498
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 22 |
| WIPO Patent Applications | 8 |
| Japanese Patent Applications | 10 |
| Clinical Trial Progress | Phase 2 (2007-01-26) |
| Vendors | 58 |
Recent Clinical Trials for SB-705498
| Title | Sponsor | Phase |
|---|---|---|
| Intranasal SB-705498 in Allergic Rhinitis (AR) Patients | GlaxoSmithKline | Phase 2 |
| A Study to Investigate the Effect of SB-705498 on Chronic Cough | GlaxoSmithKline | Phase 2 |
| SB705498 Proof of Concept Chamber Challenge in Subjects With Non Allergic Rhinitis | GlaxoSmithKline | Phase 2 |
Clinical Trial Summary for SB-705498
Top disease conditions for SB-705498
Top clinical trial sponsors for SB-705498
US Patents for SB-705498
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
